Kikuchi-Fujimoto disease by unknown
BioMed Central
Orphanet Journal of Rare Diseases
ssOpen AcceReview
Kikuchi-Fujimoto disease
Xavier Bosch*1 and Antonio Guilabert2
Address: 1Department of Internal Medicine, Hospital Clinic, University of Barcelona, Spain and 2Department of Dermatology, Hospital Clinic, 
University of Barcelona, Spain
Email: Xavier Bosch* - xbosch@teleline.es; Antonio Guilabert - tonovidal@telefonica.net
* Corresponding author    
Abstract
Kikuchi-Fujimoto disease (KFD) is a benign and self-limited disorder, characterized by regional
cervical lymphadenopathy with tenderness, usually accompanied with mild fever and night sweats.
Less frequent symptoms include weight loss, nausea, vomiting, sore throat. Kikuchi-Fujimoto
disease is an extremely rare disease known to have a worldwide distribution with higher prevalence
among Japanese and other Asiatic individuals. The clinical, histopathological and
immunohistochemical features appear to point to a viral etiology, a hypothesis that still has not
been proven. KFD is generally diagnosed on the basis of an excisional biopsy of affected lymph
nodes. Its recognition is crucial especially because this disease can be mistaken for systemic lupus
erythematosus, malignant lymphoma or even, though rarely, for adenocarcinoma. Clinicians' and
pathologists' awareness of this disorder may help prevent misdiagnsois and inappropriate
treatment. The diagnosis of KFD merits active consideration in any nodal biopsy showing
fragmentation, necrosis and karyorrhexis, especially in young individuals presenting with posterior
cervical lymphadenopathy. Treatment is symptomatic (analgesics-antipyretics, non-steroidal anti-
inflammatory drugs and, rarely, corticosteroids). Spontaneous recovery occurs in 1 to 4 months.
Patients with Kikuchi-Fujimoto disease should be followed-up for several years to survey the
possibility of the development of systemic lupus erythematosus.





Kikuchi-Fujimoto disease (KFD) is an enigmatic, benign
and self-limited syndrome characterized by regional lym-
phadenopathy with tenderness, predominantly in the cer-
vical region, usually accompanied by mild fever and night
sweats.
Initially described in Japan, KFD was first reported in
1972 almost simultaneously by Kikuchi [1] and by Fujim-
oto et al. [2] as a lymphadenitis with focal proliferation of
reticular cells accompanied by numerous histiocytes and
extensive nuclear debris [3].
Epidemiology
Kikuchi-Fujimoto disease is an extremely rare disease
known to have a worldwide distribution with a higher
prevalence among Japanese and other Asiatic individuals
[4]. Only isolated cases are reported in Europe. Affected
patients are most often young adults under the age of 30
years; the disease is seldom reported in children. A female
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ture (female to male ratio 4:1). Recent reports seem to
indicate that the female preponderance was overempha-
sized in the past and that the actual ratio is closer to 1:1
[4,5].
Etiology and pathogenesis
There is much speculation about the etiology of KFD. A
viral or autoimmune cause has been suggested. The role of
Epstein-Barr virus, as well as other viruses (HHV6, HHV8,
parvovirus B19) in the pathogenesis of KFD remains con-
troversial and not convincingly demonstrated [4]. A viral
infection is, nonetheless, possible by virtue of clinical
manifestations, as described by Unger et al. [6] that
include upper respiratory prodrome, atypical lymphocy-
tosis and lack of response to antibiotic therapy, and cer-
tain histopathologic features (i.e., T-cells as revealed by
immunological marker studies). KFD has also been
recorded in HIV- and HTLV-1-positive patients [7].
On the other hand, electron microscopic studies have
identified tubular reticular structures in the cytoplasm of
stimulated lymphocytes and histiocytes in patients with
KFD [3]. Since these structures have also been noted
within endothelial cells and lymphocytes of patients with
systemic lupus erythematosus (SLE) and other autoim-
mune disorders, some authors hypothesized that KFD
may reflect a self-limited autoimmune condition induced
by virus-infected transformed lymphocytes [8]. It is possi-
ble that KFD may represent an exuberant T-cell mediated
immune response in a genetically susceptible individual
to a variety of non-specific stimuli [4].
Although the mechanism of cell death involved in KFD
has not been extensively studied, Ohshima et al. have
shown that apoptotic cell death may play a role in the
pathogenesis of the disease [9]. According to these
authors, proliferating CD8 positive T-cells may act as "kill-
ers" and "victims" in the apoptotic process via Fas- and
perforine- pathways.
Clinical manifestations
The onset of KFD is acute or subacute, evolving over a
period of two to three weeks. Cervical lymphadenopathy
is almost always present consisting of tender lymph nodes
that involve mainly the posterior cervical triangle. Lymph
node size has been found to range from 0.5 to 4 cm, but
it may reach 5 to 6 cm and rarely larger than 6 cm. Gener-
alized lymphadenopathy can occur [5,10] but is very rare.
In addition to lymphadenopathy, 30 to 50% of patients
with KFD may have fever, usually of low-grade, associated
with upper respiratory symptoms. Less frequent symp-
toms include weight loss, nausea, vomiting, sore throat
and night sweats [11,12]. Leukopenia can be found in up
to 50% of the cases. Atypical lymphocytes in the periph-
eral blood have also been observed. Involvement of
extranodal sites in KFD is uncommon but skin, eye and
bone marrow affection, and liver dysfunction have been
reported [4]. KFD has also been reported as a cause of pro-
longed fever of unknown origin [13]. Although the dis-
ease has been linked to SLE, as well as to other
autoimmune conditions [4,14], the real strength of such
associations remains to be clarified. There have been anec-
dotal reports of unusual features of KFD including carci-
noma [15], diffuse large B-cell lymphoma [16] and
hemophagocytic syndrome [17]. There are occasional
reports describing cases of extranodal skin involvement
or, even more rarely, of fatal multicentric disease.
Diagnosis
Kikuchi-Fujimoto disease is generally diagnosed on the
basis of an excisional biopsy of affected lymph nodes. No
specific diagnostic laboratory tests are available. The
results of a wide range of laboratory studies are usually
normal. Nevertheless, some patients have anemia, slight
elevation of the erythrocyte sedimentation rate and even
leukopenia. Of note, one third of patients present atypical
peripheral blood lymphocytes [5]. Characteristic his-
topathologic findings of KFD include irregular paracorti-
cal areas of coagulative necrosis with abundant
karyorrhectic debris, which can distort the nodal architec-
ture, and large number of different types of histiocytes at
the margin of the necrotic areas. The karyorrhectic foci are
formed by different cellular types, predominantly histio-
cytes and plasmacytoid monocytes but also immunob-
lasts and small and large lymphocytes. Neutrophils are
characteristically absent and plasma cells are either absent
or scarce. Importantly, atypia in the reactive immunoblas-
tic component is not uncommon and can be mistaken for
lymphoma [18]. The immunophenotype of KFD typically
consists of a predominance of T-cells, with very few B-
cells. There is an abundance of CD8+ T-cells over CD4+.
The histiocytes express histiocyte-associated antigens such
as lysozyme, myeloperoxidase (MPO) and CD68.
Finally, striking plasmacytoid monocytes are also positive
for CD68 but not for MPO [4].
Differential diagnosis
Although KFD is considered very uncommon, this disor-
der must be included in the differential diagnosis of
'lymph node enlargement' since its course and treatment
differ dramatically from those of lymphoma, tuberculosis
and SLE. The histological differential diagnosis of KFD
mainly includes reactive lesions as lymphadenitis associ-
ated with SLE or herpes simplex, non-Hodgkin's lym-
phoma, plasmacytoid T-cell leukemia, Kawasaki's disease,
myeloid tumor and even metastasic adenocarcinoma [4].Page 2 of 3
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The differentiation of KFD from SLE can sometimes be
problematic because both can show similar clinical and
histological features. Furthermore, KFD has been reported
in association with SLE. In this case, before making the
diagnosis of KFD, laboratory tests including C3, C4, anti-
Sm, and LE cells are needed to rule out SLE.
The diagnosis of KFD is generally not difficult, although
early lesions lacking overt necrosis can be misdiagnosed
as malignant lymphoma, due to the presence of abundant
immunoblasts [7]. Features of KFD that may help prevent
its misdiagnosis as malignant lymphoma include incom-
plete architectural effacement with patent sinuses, pres-
ence of numerous reactive histiocytes, relatively low
mitotic rates, absence of Reed-Sternberg cells.
The recognition of KFD is necessary because one can avoid
laborious investigation for infectious and lymphoprolifer-
ative diseases.
Clinical course and management
Kikuchi-Fujimoto disease is typically self-limited within
one to four months. A low but possible recurrence rate of
3 to 4% has been reported [3]. In some few patients, SLE
may occur some years later. No risk to other family mem-
bers is felt to be associated with KFD [7]. Symptomatic
measures aimed to relief the distressing local and systemic
complains should be employed. Analgesics-antipyretics
and nonsteroidal anti-inflammatory drugs may be used to
alleviate lymph node tenderness and fever. The use of cor-
ticosteroids has been recommended in severe extranodal
or generalized KFD but is of uncertain efficacy. Surgical
consultation may be indicated for a diagnostic excisional
lymph node biopsy. Patients with KFD require a system-
atic survey and regular follow-up for several years to rule
out the development of SLE. The cervical lymphadenopa-
thy runs a benign course and appears to resolve spontane-
ously 1 to 6 months after definite diagnosis.
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